These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2328553)

  • 1. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings.
    Adamus WS; Heuer HO; Meade CJ; Schilling JC
    Clin Pharmacol Ther; 1990 Apr; 47(4):456-62. PubMed ID: 2328553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation.
    Adamus WS; Heuer H; Meade CJ; Frey G; Brecht HM
    Eur J Clin Pharmacol; 1988; 35(3):237-40. PubMed ID: 3181277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability, and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects.
    Adamus WS; Heuer H; Meade CJ; Brecht HM
    Clin Pharmacol Ther; 1989 Mar; 45(3):270-6. PubMed ID: 2920502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
    Adamus WS; Heuer H; Meade CJ
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
    Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
    Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
    Johnson PR; Armour CL; Black JL
    Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
    Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PAF antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep.
    Solèr M; Sielczak MW; Abraham WM
    J Appl Physiol (1985); 1989 Jul; 67(1):406-13. PubMed ID: 2759969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
    Casals-Stenzel J; Franke J; Friedrich T; Lichey J
    Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma.
    Wilkens JH; Wilkens H; Uffmann J; Bövers J; Fabel H; Frölich JC
    Br J Clin Pharmacol; 1990 Jan; 29(1):85-91. PubMed ID: 2297463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086.
    Lohmann HF; Adamus WS; Meade CJ
    Lancet; 1988 Nov; 2(8620):1147. PubMed ID: 2903365
    [No Abstract]   [Full Text] [Related]  

  • 17. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.
    Brambilla A; Ghiorzi A; Giachetti A
    Pharmacol Res Commun; 1987 Feb; 19(2):147-51. PubMed ID: 3588650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor (Paf) antagonist, WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis.
    Stanton AW; Izumi T; Antoniw JW; Piper PJ
    Br J Pharmacol; 1989 Jul; 97(3):643-6. PubMed ID: 2758235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.